TrialMultiple sclerosis (Houndmills, Basingstoke, England)2018

Improved cognitive outcomes in patients with relapsing-remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study.

Ralph Hb Benedict et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.